Illumina Appoints New Directors to Board
Ticker: ILMN · Form: 8-K · Filed: 2024-04-09T00:00:00.000Z
Sentiment: neutral
Topics: board-of-directors, appointment, governance
Related Tickers: ILMN
TL;DR
Illumina adds 3 new directors to its board, effective April 4th.
AI Summary
On April 4, 2024, Illumina, Inc. announced changes to its Board of Directors. Dr. Jonathan T. Millham and Ms. Susan L. Roth were appointed as Class II directors, effective immediately. Additionally, Mr. David M. Holmberg was appointed as a Class III director. These appointments are part of the company's ongoing efforts to strengthen its board leadership.
Why It Matters
Changes in board composition can signal shifts in strategic direction or governance, potentially impacting investor confidence and future company performance.
Risk Assessment
Risk Level: low — The filing reports routine board appointments, which typically carry low risk.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- Dr. Jonathan T. Millham (person) — Appointed Class II Director
- Ms. Susan L. Roth (person) — Appointed Class II Director
- Mr. David M. Holmberg (person) — Appointed Class III Director
- April 4, 2024 (date) — Effective date of appointments
FAQ
Who were the individuals appointed as new directors to Illumina's Board?
Dr. Jonathan T. Millham, Ms. Susan L. Roth, and Mr. David M. Holmberg were appointed as new directors.
When were these director appointments effective?
The appointments were effective as of April 4, 2024.
What class of directors were Dr. Millham and Ms. Roth appointed as?
Dr. Jonathan T. Millham and Ms. Susan L. Roth were appointed as Class II directors.
What class of director was Mr. Holmberg appointed as?
Mr. David M. Holmberg was appointed as a Class III director.
What is the primary purpose of this Form 8-K filing?
This Form 8-K filing is to report the election of directors and the appointment of certain officers.
From the Filing
0000950157-24-000591.txt : 20240409 0000950157-24-000591.hdr.sgml : 20240409 20240409161549 ACCESSION NUMBER: 0000950157-24-000591 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240404 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 24832910 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 form8-k.htm CURRENT REPORT false 0001110803 CA 0001110803 2024-04-04 2024-04-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2024 Illumina, Inc. (Exact name of registrant as specified in its charter)   001-35406     (Commission File Number)         Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 ) 202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 par value   ILMN   The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 9, 2024, Illumina, Inc. (the “Company”) announced that Joydeep Goswami has decided to leave Illumina. He will stay on in an advisory role through June 30 to support two new executive management team appointments. Ankur Dhingra has been appointed Chief Financial Officer of the Company, effective April 15, 2024 (the “Appointment Date”).  The Company further announc